Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Non-alcoholic Fatty Liver Disease × Lisinopril × 1 year × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Radiation Injuries 1 Prostatic Neoplasms 1 Non-alcoholic Fatty Liver Disease 1 Carcinoma, Hepatocellular 1

Interventions

Ursodeoxycholic Acid 1 Surveys and Questionnaires 1 Specimen Handling 1 Sampling Studies 1 Phlebotomy 1 Pancreaticoduodenectomy 1 Metformin 1 Magnetic Resonance Spectroscopy 1 Lisinopril 1 Hypothermia, Induced 1 Exercise 1 Docosahexaenoic Acids 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04550481 2026-01-21

Role of Lisinopril in Preventing the Progression of Non-Alcoholic Fatty Liver Disease, RELIEF-NAFLD Study

Northwestern University

Phase 2 Active not recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Non-alcoholic Fatty Liver Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡